Neurophyxia
Phase 1Neurophyxia is an innovative clinical-stage drug development company, developing novel drugs to reduce the deleterious effects of oxygen shortage in the brain.
Founded
2016
Focus
Small Molecules
About
Neurophyxia is an innovative clinical-stage drug development company, developing novel drugs to reduce the deleterious effects of oxygen shortage in the brain.
Funding History
2Total raised: $3M
Grant$500KEurostarsJun 15, 2021
Seed$2.5MBioGeneration VenturesJun 15, 2021
Company Info
TypePrivate
Founded2016
LocationLeiden, Netherlands
StagePhase 1
Contact
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile